Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy? Fujihara K, Nakashima I Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e38. Epub 2014 Oct 09. PMID: 25340089. Abstract CommentRecommendBookmarkWatch